Cut and Paste: Treating Spinal Muscular Atrophy with Nusinersen

How Spinraza (nusinersen) and Evrysdi treat Spinal Muscular Atrophy (SMA) through splice-switchingПодробнее

Discovering Zolgensma for SMA: What goes into making the most expensive drug on the market?Подробнее

Spinal Muscular Atrophy 2019: Approved Treatment and Upcoming Therapeutic StrategiesПодробнее

Colorado Virtual Education Screening: Spinal Muscular Atrophy (SMA)Подробнее

Nusinersen (SpinrazaTM): The First FDA Approved Treatment for SMAПодробнее

SPINRAZA® (nusinersen) Mechanism of Action in Spinal Muscular AtrophyПодробнее

Nusinersen: ASO(Anti-Sense- Oligonucleotide) Therapy toward Spinal Muscular Atrophy (SMA) #Code: 198Подробнее

New Clinical Data on Adult Nusinersen treated Patients with SMAПодробнее

Nusinersen Treatment for Older Patients with SMAПодробнее

Nusinersen: The First Approval for Spinal Muscular AtrophyПодробнее

Treating spinal muscular atrophy in adult patientsПодробнее

Nusinersen Treatment Outcomes in Later Onset SMAПодробнее

Real-World Experience Treating SMA With NusinersenПодробнее

Nusinersen Treatment for SMAПодробнее

Mechanism of Disease: SMAПодробнее

U.S. FDA Approves Biogen’s SPINRAZA™ (nusinersen), The First Treatment for Spinal Muscular AtrophyПодробнее

The History of Spinal Muscular Atrophy TreatmentПодробнее

Understanding Spinal Muscular Atrophy (SMA)Подробнее

SMA Type 1: How Gene Therapy WorksПодробнее